Serum Exosome Isolation by Size-Exclusion Chromatography for the Discovery and Validation of Preeclampsia-Associated Biomarkers.

Exosomes are extracellular nanovesicles of complex and heterogeneous composition that are released in biofluids such as blood. The interest in the characterization of exosomal biochemistry has increased over the last few years as they convey cellular proteins, lipids, and RNA that might reflect the biological or pathological condition of the source cell. In particular, association of changes of exosome proteins with specific pathogenic processes arises as a promising method to identify disease biomarkers as for the pregnancy-related preeclampsia. However, the overlapping physicochemical and structural characteristics of different types of extracellular vesicles have hindered the consolidation of universally accepted and standardized purification or enrichment protocols. Thus, it has been recently demonstrated that the exosomal protein profile resulting from in-depth proteomics analyses is highly dependent on the preparation protocol used, which will determine the particle type specificity and the presence/absence of contaminating proteins.In this chapter, an isolation method of serum exosomes based on size-exclusion chromatography (SEC) using qEV columns (Izon) is described. We show that this method is fast and reliable, as the population of exosomes isolated is homogeneous in terms of size, morphology, and protein composition. This exosome enrichment method is compatible with downstream qualitative and quantitative proteomic analysis of the samples.

[1]  Ruedi Aebersold,et al.  Mass-spectrometric exploration of proteome structure and function , 2016, Nature.

[2]  M. Baker,et al.  High‐abundance protein depletion: Comparison of methods for human plasma biomarker discovery , 2010, Electrophoresis.

[3]  Thomas J. Wang,et al.  The search for new cardiovascular biomarkers , 2008, Nature.

[4]  Veronika A. Glukhova,et al.  Contribution of protein fractionation to depth of analysis of the serum and plasma proteomes. , 2007, Journal of proteome research.

[5]  G. Gores,et al.  Serum extracellular vesicles contain protein biomarkers for primary sclerosing cholangitis and cholangiocarcinoma , 2017, Hepatology.

[6]  S. Mathivanan,et al.  Exosomes in bodily fluids are a highly stable resource of disease biomarkers , 2015, Proteomics. Clinical applications.

[7]  A. Möller,et al.  Optimized exosome isolation protocol for cell culture supernatant and human plasma , 2015, Journal of extracellular vesicles.

[8]  R. Aebersold,et al.  Selected reaction monitoring for quantitative proteomics: a tutorial , 2008, Molecular systems biology.

[9]  R. Levine,et al.  Preeclampsia, a Disease of the Maternal Endothelium: The Role of Antiangiogenic Factors and Implications for Later Cardiovascular Disease , 2011, Circulation.

[10]  S. Hanash,et al.  Mining the plasma proteome for cancer biomarkers , 2008, Nature.

[11]  C. Ris-Stalpers,et al.  Accuracy of circulating placental growth factor, vascular endothelial growth factor, soluble fms‐like tyrosine kinase 1 and soluble endoglin in the prediction of pre‐eclampsia: a systematic review and meta‐analysis , 2012, BJOG : an international journal of obstetrics and gynaecology.

[12]  E. Buzás,et al.  Best practice of identification and proteomic analysis of extracellular vesicles in human health and disease , 2017, Expert review of proteomics.

[13]  T. Libermann,et al.  Soluble endoglin contributes to the pathogenesis of preeclampsia , 2006, Nature Medicine.

[14]  T. Libermann,et al.  Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia , 2003 .

[15]  M. I. Mora,et al.  Multicentric study of the effect of pre-analytical variables in the quality of plasma samples stored in biobanks using different complementary proteomic methods. , 2017, Journal of proteomics.

[16]  S. Davidge,et al.  Molecular mechanisms of maternal vascular dysfunction in preeclampsia. , 2015, Trends in molecular medicine.

[17]  S. Mathivanan,et al.  Exosomes: extracellular organelles important in intercellular communication. , 2010, Journal of proteomics.

[18]  D. Speicher,et al.  Systematic comparison of fractionation methods for in-depth analysis of plasma proteomes. , 2012, Journal of proteome research.

[19]  N. Anderson,et al.  The Human Plasma Proteome , 2002, Molecular & Cellular Proteomics.